Braxia Scientific Corp
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery metho… Read more
Braxia Scientific Corp (BRAXF) - Total Liabilities
Latest total liabilities as of December 2023: $2.70 Million USD
Based on the latest financial reports, Braxia Scientific Corp (BRAXF) has total liabilities worth $2.70 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Braxia Scientific Corp - Total Liabilities Trend (2020–2023)
This chart illustrates how Braxia Scientific Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Braxia Scientific Corp Competitors by Total Liabilities
The table below lists competitors of Braxia Scientific Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AUSTOCK GRP
BE:5A9
|
Germany | €3.44 Billion |
|
ACRO Biomedical Co Ltd
PINK:ACBM
|
USA | $436.94K |
|
SINGTEL 1000
BE:SIT4
|
Germany | €21.23 Billion |
|
ARTPRICE COM (AJP.SG)
STU:AJP
|
Germany | €11.47 Million |
|
AMERN VANGUARD CORP
BE:AVJ
|
Germany | €454.23 Million |
|
Riverwalk Acquisition Corp.
V:RAC-P
|
Canada | CA$2.42K |
|
S&U plc
LSE:SUS
|
UK | GBX193.30 Million |
|
METSA BOARD -B-
BE:MSRB
|
Germany | €1.05 Billion |
Liability Composition Analysis (2020–2023)
This chart breaks down Braxia Scientific Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -7.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Braxia Scientific Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Braxia Scientific Corp (2020–2023)
The table below shows the annual total liabilities of Braxia Scientific Corp from 2020 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-03-31 | $2.28 Million | -14.69% |
| 2022-03-31 | $2.67 Million | +2.75% |
| 2021-03-31 | $2.60 Million | +3364.01% |
| 2020-03-31 | $75.07K | -- |